Hồ sơ nguồn sơ cấp
FDA đã ban hành thư phản hồi hoàn chỉnh cho BLA 761463 ngày 2025-09-22.
. FOOD & DRUG INISTRATION BLA 761463 THƯ PHẢN HỒI HOÀN CHỈNH Scholar Rock, Inc. Attention: Neda Aghajani Memar, PharmD Senior Director, Global Regulatory Affairs 301 Binney Street, 3ra Floor Cambridge, MA 02142 Dear Dr. Memar: Please re (b) (4) fer to your biologics license application (BLA) oe for SRK-015 (apitegromab-mstn) injection, for intravenous use. We have completed our review of this application and have determined that we cannot approve tl action be! his application in its present form. We have described our reasons for this low and, where possible, our recommendations to address these issues. FACILITY INSPECTIONS Fo lowing a CGMP inspection of oo oye) , listed in this application, FDA conveyed deficiencies to the representative of the facility. The facility s